Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effects of Phoniatric PREhabilitation in Head and Neck Cancer patients on Aspiration and Preservation of Swallowing (PREHAPS): study protocol of a monocentric prospective randomized interventional outcome-blinded trial.
Kuenzel J, Duerr S, Vester S, Zeman F, Huppertz G, Koller M, Pfleger G, Woertgen A, Salloum H, Klinkhammer-Schalke M, Pukrop T, Kummer P. Kuenzel J, et al. Among authors: koller m. Trials. 2024 Mar 22;25(1):211. doi: 10.1186/s13063-024-08010-2. Trials. 2024. PMID: 38519961 Free PMC article.
Treatment of sleep apnoea early after myocardial infarction with adaptive servo-ventilation: a proof-of-concept randomised controlled trial.
Arzt M, Fox H, Stadler S, Hetzenecker A, Oldenburg O, Hamer OW, Poschenrieder F, Wiest C, Tanacli R, Kelle S, Bruch L, Seidel M, Koller M, Zeman F, Buchner S; TEAM-ASV I Investigators. Arzt M, et al. Among authors: koller m. Eur Respir J. 2024 Sep 5;64(3):2302338. doi: 10.1183/13993003.02338-2023. Print 2024 Sep. Eur Respir J. 2024. PMID: 38991707 Clinical Trial.
Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial.
Corbacioglu S, Lode H, Ellinger S, Zeman F, Suttorp M, Escherich G, Bochennek K, Gruhn B, Lang P, Rohde M, Debatin KM, Steinbach D, Beilken A, Ladenstein R, Spachtholz R, Heiss P, Hellwig D, Tröger A, Koller M, Menhart K, Riemenschneider MJ, Zoubaa S, Kietz S, Jakob M, Sommer G, Heise T, Hundsdörfer P, Kühnle I, Dilloo D, Schönberger S, Schwabe G, von Luettichau I, Graf N, Schlegel PG, Frühwald M, Jorch N, Paulussen M, Schneider DT, Metzler M, Leipold A, Nathrath M, Imschweiler T, Christiansen H, Schmid I, Crazzolara R, Niktoreh N, Cario G, Faber J, Demmert M, Babor F, Fröhlich B, Bielack S, Bernig T, Greil J, Eggert A, Simon T, Foell J. Corbacioglu S, et al. Among authors: koller m. Lancet Oncol. 2024 Jul;25(7):922-932. doi: 10.1016/S1470-2045(24)00202-X. Lancet Oncol. 2024. PMID: 38936379 Free article. Clinical Trial.
Introducing the OECD guidance document on occupational biomonitoring: A harmonized methodology for deriving occupational biomonitoring levels (OBL).
Hopf NB, Bessems J, Santonen T, Viegas S, Casteleyn L, Poddalgoda D, Lamkarkach F, Göen T, Zare Jeddi M, Koller M, Rousselle C, Jones K, Schmid K, FitzGerald R, Bader M, Takaki K, Browne P, Väänänen V, Duca RC, Pasanen-Kase R. Hopf NB, et al. Among authors: koller m. Toxicol Lett. 2024 Dec 15;403:132-143. doi: 10.1016/j.toxlet.2024.12.006. Online ahead of print. Toxicol Lett. 2024. PMID: 39681241 Free article.
1,183 results